The CONTRIBUTE Study is looking at whether a study medication (a new medication that is under development) is safe and effective in people with ulcerative colitis that is not well controlled using their current medication.
You might be able to participate if you:
- are between 18 and 75 years of age
- have been diagnosed with mild of moderate ulcerative colitis
- are having ulcerative colitis symptoms even though you have been taking tables such as sulfasalazine (Azulfidine), mesalamine (Pentasa, Rowasa, Asacol, Lialda) or olsalazine (Dipentum) for at least 6 weeks.
The CONTRIBUTE Study will last for approximately 12 weeks and will require six visits to the study center. If you are eligible to participate in the CONTRIBUTE Study, you will receive study-related medication and health assessments at no cost and may be reimbursed for transportation costs.
Think this Study may be right for you?
Email your contact information...
or Call 228.872.7612 and ask for Luan
**You cannot make appointments with this form. Please leave your contact information and we will get back to you soon**